Saamya Biotech India Ltd IPO Message Board (Page 11)

views of s.p tulsian----
Samay kharab hai!
Saamya Biotech (India) is entering the capital market on 25th September, 2007 with a public issue of 1.50 crore equity shares of Rs.10 each , at par, aggregating Rs.15 crores.

The company is setting up a project to manufacture Bio-Pharma ingredients Daunomycin and Hyaluronic Acid-Pharma Grade and Cosmetic Grade, with project cost of Rs.28.08 crores. This is being financed by equity of Rs.23.08 crores and term loan of Rs.5 crores, being availed from SBI. The products of the company are low volume - high value and due to this, plant installed capacity of Daunomycin would be 225 kg per annum, Hyaluronic Acid (Pharma Grade) would be 125 kg per annum while of Cosmetic Grade it would be 550 kg per annum. The commercial production is expected to start by March 2008. Presently, there are no activities being carried out by the company.

The promoters of the company Dr. Reddy and Mrs. Reddy, both are medicine qualified doctors, who are also promoters of Visu International Ltd. SEBI had imposed a penalty of Rs.50,000 on Visu for violations of SEBI regulations. The financial performance of this company has been nothing great. The paid-up equity of the company is Rs.35.33 crores, in which promoters’ stake is just 7%, with book-value of Rs.16.40, on 31-03-07. The share is ruling at Rs.16. EPS of the company for FY 07 was at Rs.4 which is discounted by 4 times. Really, poor discounting to the promoters and company.

Post issue, equity of the company at Rs.23.08 crores would be very high and may be difficult to service. Low promoters’ stake of 35% is also a dampener. The share is listing only on BSE.

Considering the size and financing pattern of the project and also track record of the promoters’, investment is not advised in this par issue. At Rs.10 also, when other companies are issuing its paper at premium, it is not attractive enough for the investors.

supreem infra is mind blowing issue grey market premium is Rs 70.00

please comment towards ipo which worth to apply

JUST HAVE A LOOK AT "Ammana Bio Pharma Limited" WHICH ALSO STARTED FROM AP. IPO MIGHT BE HELD UP AND YOUR MONEY MIGHT BE LOCKED...PEOPLE ARE STILL FIGHTING TO GET BACK THEIR FROM Ammana...BE CAREFUL ABOUT THIS WHILE INVESTING..

Compare to others this ipo is good

Can any body suggested to invest in this IPO? Tell me the number of shares too?

Is it good to apply in this IPO? Is its Price band fixed? Can any body tell what is minimum Lot to apply?

The company proposes to set up facilities for an aggregate installed capacity of 9.2 tpa bulk active pharmaceutical ingredients of high value biopharmaceuticals.

what is it doing now

I would recomond to apply this IPO

Guys,

Never go by grey market premium for low cap stocks......
Things can change fast.... U can be lucky sometimes... If u fall, It cud be a very big fall...

How about the fundamentals? PE of peers and the management?

grey market premium of Saamya Bio is 5 to 6 Rs.

1. IPO money will be held up for one month.
2. Fixed price issue and will list on only BSE
3. May not give huge premium, may give around 20% subject to market conditions

Please give us valid reason for apply just don't send message for apply

Please post the financials for the company